InsiderDB

Insmed (INSM)

Healthcare · Biotechnology

2 members of Congress have disclosed 10 trades in Insmed (INSM) since 2022: 2 buys and 8 sales. The most recent was disclosed on Jul 7, 2026.

Trades disclosed
10
Members trading
2
Buys / sells
2 / 8
Reported value
$10K–$150K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow INSM

What else is happening at INSM

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. INSMLobbying report·Lobbying disclosures

    INSM: third_quarter 2026 lobbying report

    MFN Issues.

    Public: Oct 19, 2026, 7:29 AM EDTOriginal source ↗
  2. INSMLobbying report·Lobbying disclosures

    INSM: third_quarter 2026 lobbying report

    General Issues of interest to pharmaceutical companies Issues related to Medicare reimbursement of pharmaceutical products

    Public: Oct 18, 2026, 6:49 PM EDTOriginal source ↗
  3. INSMLobbying report·Lobbying disclosures

    INSM: second_quarter 2026 lobbying report

    General Issues of interest to pharmaceutical companies Issues related to Medicare reimbursement of pharmaceutical products

    Public: Jul 20, 2026, 3:07 PM EDTOriginal source ↗
  4. INSMLobbying report·Lobbying disclosures

    INSM: second_quarter 2026 lobbying report

    MFN Issues.

    Public: Jul 19, 2026, 8:46 AM EDTOriginal source ↗
  5. INSMLobbying report·Lobbying disclosures

    INSM: second_quarter 2026 lobbying report

    MFN Issues.

    Public: Jul 17, 2026, 6:51 AM EDTOriginal source ↗

Who traded INSM

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.